Spoorstudent schreef op 10 februari 2025 09:24:
I hit some great clinical sessions this morning, it's always inspiring to see new science and clinical progress.
Anna van Muyden at Galapagos presented a promising view of the ATALANTA-1a trail featuring a 7 day vein-to-vein model.
Eytan Breman at Celyad Oncology showcased the tandem antigen construct and miRNA scaffold used to supercharge CAR-T cells for solid tumour indications.
Keep the innovation coming! ??